Aequus Pharmaceuticals Inc. (AQSZF) - Latest Market Data

Price & Market Data

Price: $0.0023

Daily Change: $0.00 / 0.00%

Daily Range: $0 - $0

Market Cap: $305,059

Daily Volume: 0

Performance Metrics

1 Week: 360.0%

1 Month: 21.05%

3 Months: 1,050%

6 Months: 91.67%

1 Year: -42.50%

YTD: 91.67%

About Aequus Pharmaceuticals Inc. (AQSZF)

Discover the market presence of Aequus Pharmaceuticals Inc. (AQSZF). Price: 0.0023, daily change: $0.00 / 0.00%. Market cap: 305,059. Performance across all periods for a clear financial view.

Details

Aequus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. The company offers ZIMED PF, a preservative-free bimatoprost prescription drug for the for the reduction of elevated interocular pressure in patients with open angle glaucoma or ocular hypertension. It also develops REV-0100, which is in pre-clinical trial for the treatment of stargardt disease. Aequus Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.

Selected stocks

ABAXX Technologies Inc. (ABXXF)

inTerra Resources Corp. (ITRX)

China Bluechemical Ltd. (CBLUF)

Air France-KLM (AFRAF)

Renalytix plc (RNLXY)